Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 333 Neoplasms 221 Prostatic Neoplasms 197 Carcinoma, Non-Small-Cell Lung 156 Lung Neoplasms 135 Pancreatic Neoplasms 118 Colorectal Neoplasms 103 Neoplasm Metastasis 100 Carcinoma, Hepatocellular 96 Leukemia, Myeloid, Acute 94 Multiple Myeloma 91 Brain Neoplasms 89 Lymphoma 86 Head and Neck Neoplasms 76 Melanoma 73 Ovarian Neoplasms 72 Leukemia 71 Leukemia, Lymphocytic, Chronic, B-Cell 69 Glioblastoma 69 Precursor Cell Lymphoblastic Leukemia-Lymphoma 66 Colonic Neoplasms 61 Recurrence 59 Lymphoma, Non-Hodgkin 54 Rectal Neoplasms 50 Hematologic Neoplasms 50 Lymphoma, Follicular 49 Glioma 49 Squamous Cell Carcinoma of Head and Neck 47 Lymphoma, Large B-Cell, Diffuse 47 Carcinoma, Renal Cell 47

Interventions

fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER × Hypoxic Tumours × Clear all

NCT00756691 2017-11-14

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

AHS Cancer Control Alberta

Hypoxic Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡